Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)
cfDNA、肿瘤分数和突变的基线水平和动态变化,以预测接受一线阿特珠单抗和化疗治疗的小细胞肺癌(SCLC)患者的临床病程:一项假设生成研究(CATS/ML43257)
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03434-3
Pasello, Giulia; Pigato, Giulia; Scattolin, Daniela; Lando, Stefania; Potente, Sara; Romualdi, Chiara; Roma, Anna; Resi, Maria Vittoria; Frega, Stefano; Ferro, Alessandra; Maso, Alessandro Dal; Bonanno, Laura; Guarneri, Valentina; Lazzarini, Elisabetta; Indraccolo, Stefano